Globus Medical (GMED) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.
Total Assets Chart for Globus Medical
Globus Medical (GMED) total assets for FY2025 were USD 5.3B, a 1.0% change from FY2024. Globus Medical's total assets grew from USD 266.6M in 2010 to USD 5.3B in 2025 (1889.2% over 15 years). Total assets compound annual growth rate: 5-year CAGR of 25.9%, 10-year CAGR of 20.3%.
Total Assets (US Dollars)
R&D as % of Revenue
Key Stats
- Market Cap
- $10.26B
- Implied Share Price
- $91.76
- Enterprise Value
- $9.45B
- Revenue (TTM)
- $3.14B
- EBITDA
- $1.01B
- Profit Margin
- 17.03%
- Trailing P/E
- 19.60
- Forward P/E
- 13.87
- Price/Book (MRQ)
- 2.08
- Price/Sales (TTM)
- 3.26
- EV/EBITDA
- 9.90
- EV/Revenue
- 3.00
- Dividend Yield
- —
- Book Value
- $35.52
- Free Cash Flow (FY2025)
- $588.77M
- Free Cash Flow Yield
- 5.74%
Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.